- [citation needed] In
April 2016, Singerman's
largest investment to date,
Stemcentrx, was
acquired by
pharmaceutical company AbbVie in a
transaction valuing...
-
November 2016. On 28
April 2016, the
company announced it
would acquire Stemcentrx for up to $9.8 billion. A day later, the
company announced an expansion...
- 2020
December 2021 IPO 11.6
United States Sanjit Biswas, John
Bicket Stemcentrx 5
September 2015
April 2016
Acquired 5.8
United States dLocal 5.0 April...
-
targeting the
protein DLL3 on
tumor cells. It was
originally developed by
Stemcentrx and was
purchased by AbbVie. It was
tested for use in small-cell lung...
- Betts-LaCroix is also a
biotech angel investor in such
companies as
StemCentrx,
Recursion Pharma and
Spring Discovery, as well as a part-time contributor...
- Palantir, and made
other investments including in AirBnB, Lyft, Spotify, and
Stemcentrx,
which AbbVie acquired for $10
billion a few
years after Founders Fund's...
-
conjugate in
development for the
treatment of cancer. It was
created by
Stemcentrx and is
being developed by Pfizer. The drug is an anti-PTK7 monoclonal...
- 1126/scitranslmed.aac9459. PMC 4934375. PMID 26311731. "Rovalpituzumab
tesirine -
Stemcentrx - AdisInsight". GeneReviews/NIH/NCBI/UW
entry on
Spondylocostal Dysostosis...
